Deutsche Bank Firm on Biotech Stocks to Buy
Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the ...Read Full Story »
Posts related to ‘ALXN’
Read Full Story »
UBS Top Picks for Second Quarter for 25 Percent Gains (ALXN, ACI, C, CIE, DAL, HAL, BLOX, KRA, MNST, NCT, ROST, TIBX, WCRX, WFM)
When we started off 2013, most of the Wall St. firms we follow put out their top stock picks for the year. We covered those various lists so our readers ...Read Full Story »
ETF Folly: Biotech ETFs, Nothing but Confusion
24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector performed ...Read Full Story »
Top Analyst Upgrades and Downgrades (ACMP, ALXN, ADI, BIDU, BCS, ESRX, GMCR, LOW, MM, NTSP, RDN, SEE, SPLS, HOT, WIN)
These are some of this Wednesday's top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Access Midstream Partners L.P. (NYSE: ACMP) reiterated Outperform but on Focus List ...Read Full Story »
Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)
The dread and fear that can come with a cancer diagnosis have their roots in its killer nature. It is the number two cause of death in Americans, second only ...Read Full Story »
The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)
Big biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. ...Read Full Story »
How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)
The largest biotech stocks have been great performers in 2012. The question is whether that can be sustained in 2013. If Wall St. analysts are correct, biotech and biohealth investors ...Read Full Story »
Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), ...Read Full Story »
Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), ...Read Full Story »
Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold ...Read Full Story »
Short Interest in Biotech on the Rise (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)
With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August ...Read Full Story »
Short Interest in Biotech Wanes (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)
The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the ...Read Full Story »
Biotech: Vertex and VIVUS Draw Short Interest (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS)
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the ...Read Full Story »
Top Analyst Upgrades & Downgrades (ALXN, AAPL, ADP, COCO, EBAY, FFIV, INTC, NAV, ZNGA)
These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Thursday. Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) Raised to Outperform as Bull of the ...Read Full Story »
Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)
For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at least some of the same problems of Big Pharma players like ...Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (9897)
- Accounting (508)
- Active Trader (4389)
- Aerospace & Defense (229)
- Alternative Energy (1057)
- Analyst Calls (5063)
- Autos (1471)
- Banking & Finance (3788)
- Bankruptcy (281)
- Buffett (339)
- Calendar (421)
- Casinos & Hotels (99)
- Commodities & Metals (1358)
- Consumer Product (794)
- Corporate Governance (1981)
- Dividends & Buybacks (921)
- Earnings (4141)
- Economy (3691)
- Editor's Picks (516)
- ETFs & Mutual Funds (822)
- General (3836)
- Healthcare (1432)
- Housing (1033)
- Industrials (627)
- Infrastructure (596)
- International Markets (4168)
- Internet (2192)
- IPOs & Secondaries (1649)
- Jobs (158)
- Labor (654)
- Media (4201)
- Mergers & Acquisitions (2223)
- Oil & Gas (2567)
- Personal Finance (304)
- Politics (821)
- Polls (33)
- Regulation (1159)
- Retail (2580)
- Rumors (1093)
- Services (294)
- Special Report (373)
- Technology (3819)
- Telecom & Wireless (1689)
- Transportation (581)
- Value Investing (761)
